Kurtov I V, Davydkin I L, Kondurtsev V A
Klin Med (Mosk). 2009;87(11):59-62.
The aim of the work was to evaluate results of the treatment of idiopathic thrombocytopenic purpura (ITP) in terms of relationship between immunity and clinical compensation of the disease, changes in the immune status of patients with its long duration, causes of long-term success or failure of splenectomy (SE) compared with cases treated by glucocorticoids alone. The study included 76 patients with chronic ITP of less than 1 year duration divided into 2 groups. 36 of them underwent SE and 40 were given prednisolone therapy. Examination included identification of lymphocyte subpopulations by flow cytometry, besides IgA, IgM, and IgG during exacerbation and remission (absence of hemorrhagic syndrome). It was shown that the major factors exerting negative effect after SE were elevated levels of total T-lymphocytes and their subpopulations (CD4+ and CD8+, especially T-helpers), B-lymphocytes, and IgM. Lower efficiency of conservative therapy with prednisolone was due to the absence of decrease in the absolute number of T-lymphocytes and changes in IgM.
这项工作的目的是根据免疫与疾病临床代偿之间的关系、病程较长的患者免疫状态的变化、与单纯接受糖皮质激素治疗的病例相比脾切除术(SE)长期成功或失败的原因,来评估特发性血小板减少性紫癜(ITP)的治疗结果。该研究纳入了76例病程少于1年的慢性ITP患者,分为2组。其中36例接受了脾切除术,40例接受了泼尼松龙治疗。检查包括通过流式细胞术鉴定淋巴细胞亚群,以及在病情加重期和缓解期(无出血综合征)检测IgA、IgM和IgG。结果显示,脾切除术后产生负面影响的主要因素是总T淋巴细胞及其亚群(CD4+和CD8+,尤其是T辅助细胞)、B淋巴细胞和IgM水平升高。泼尼松龙保守治疗效果较低是由于T淋巴细胞绝对数量没有减少以及IgM没有变化。